Hernday Natasha

CIK 00017805474 companiesEMERYVILLE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001780547

Recent Transactions

29 trades

Award
Janux Therapeutics, Inc.$JANX
Common Stock
2025-06-11+3,750→ 8,731 total
Award
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2025-06-11+11,667→ 11,667 total
Award
XOMA Royalty Corp$XOMA
Common Stock
2025-05-21+5,971→ 9,006 total
Award
Janux Therapeutics, Inc.$JANX
Stock Option (Right to Buy)
2024-07-19+8,350→ 8,350 total
Award
Janux Therapeutics, Inc.$JANX
Common Stock
2024-07-19+2,500→ 7,500 total
Award
Janux Therapeutics, Inc.$JANX
Stock Option (Right to Buy)
2024-07-19+16,700→ 16,700 total
Award
Janux Therapeutics, Inc.$JANX
Stock Option (Right to Buy)
2024-07-19+4,111→ 4,111 total
Award
Janux Therapeutics, Inc.$JANX
Common Stock
2024-07-19+1,231→ 6,231 total
Award
Janux Therapeutics, Inc.$JANX
Common Stock
2024-07-19+5,000→ 5,000 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−17,500→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−7,650→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−15,000→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−10,000→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−10,000→ 0 total
Award
XOMA Royalty Corp$XOMA
Non-Qualified Share Option (right to buy)
2024-05-15+4,881→ 4,881 total
Award
XOMA Royalty Corp$XOMA
Common Stock
2024-05-15+3,035→ 3,035 total
Award
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-01-02+17,500→ 17,500 total
Award
XOMA Royalty Corp$XOMA
Non-Qualified Share Option (right to buy)
2023-05-17+10,967→ 10,967 total
Award
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2023-01-03+10,000→ 10,000 total
Award
XOMA Royalty Corp$XOMA
Non-Qualified Share Option (right to buy)
2022-05-18+8,996→ 8,996 total
Award
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2022-01-03+10,000→ 10,000 total
Award
XOMA Royalty Corp$XOMA
Non-Qualified Share Option (right to buy)
2021-05-19+5,101→ 5,101 total
Award
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2021-01-04+7,650→ 7,650 total
Award
XOMA Royalty Corp$XOMA
8.625% Series A Cumulative Perpetual Preferred Stock
2020-12-15$25.00/sh+4,000→ 4,000 total
Award
ALPINE IMMUNE SCIENCES, INC.
Stock Option (right to buy)
2020-12-10+15,000→ 15,000 total
Award
PDL BIOPHARMA, INC.
Common stock
2020-08-19+25,826→ 75,826 total
Award
PDL BIOPHARMA, INC.
Stock Option (right to buy)
2020-08-19$3.63/sh+118,671→ 118,671 total
Award
XOMA Royalty Corp$XOMA
Non-Qualified Share Option (right to buy)
2020-06-30+13,251→ 13,251 total
Award
PDL BIOPHARMA, INC.
Common stock
2019-06-20+50,000→ 50,000 total

Companies

Recent Filings

Address

C/O XOMA ROYALTY CORPORATION 2200 POWELL STREET, SUITE 310

EMERYVILLE, CA, 94608

View on SEC.gov